JOHNSON DAVID EDWARD
Insider CIK 1785557 · LAB 10% owner · ALIM 10% owner · LQDA Director, 10% owner · AMAG Director, 10% owner · EXEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LQDA Liquidia Corp | A Award | 2026-06-16 | 2026-06-18 | 5,882 | — | $0 | 5,882 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2026-05-27 | 2026-05-29 | 19,133 | — | $0 | 19,133 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2026-05-19 | 2026-05-20 | 5,300 | $59.98 | $317.9K | 8,138,951 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-19 | 2026-05-20 | 5,300 | $59.98 | $317.9K | 8,133,651 | SEC↗ |
| EXEL EXELIXIS, INC. | P Buy | 2025-11-25 | 2025-11-26 | 27,532 | $43.12 | $1.19M | 1,553,262 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2025-06-17 | 2025-06-20 | 18,396 | — | $0 | 38,755 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2025-05-29 | 2025-06-02 | 21,464 | — | $0 | 21,464 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other deriv | 2024-09-16 | 2024-09-18 | 800,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other deriv | 2024-09-16 | 2024-09-18 | 1 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other | 2024-09-16 | 2024-09-18 | 16,835,154 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2024-09-12 | 2024-09-12 | 1,123,595 | $8.90 | $10.00M | 8,118,592 | SEC↗ |
| LQDA Liquidia Corp | J Other | 2024-08-30 | 2024-09-04 | 3,440,948 | — | $0 | 6,994,997 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2024-08-30 | 2024-09-04 | 150,000 | $9.51 | $1.43M | 6,994,997 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2024-08-30 | 2024-09-04 | 150,000 | $9.51 | $1.43M | 6,844,997 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2024-06-20 | 2024-06-24 | 20,359 | — | $0 | 20,359 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2024-05-31 | 2024-06-04 | 42,767 | — | $0 | 42,767 | SEC↗ |
| EXEL EXELIXIS, INC. | P Buy | 2024-05-30 | 2024-05-30 | 225,000 | $20.76 | $4.67M | 1,525,730 | SEC↗ |
| EXEL EXELIXIS, INC. | P Buy | 2024-05-28 | 2024-05-30 | 200,000 | $20.32 | $4.06M | 1,300,730 | SEC↗ |
| EXEL EXELIXIS, INC. | P Buy | 2024-02-21 | 2024-02-22 | 190,000 | $20.70 | $3.93M | 1,100,730 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2023-12-14 | 2023-12-14 | 1,117,318 | $7.16 | $8.00M | 11,280,945 | SEC↗ |
| EXEL EXELIXIS, INC. | P Buy | 2023-11-27 | 2023-11-29 | 120,409 | $21.61 | $2.60M | 910,730 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2023-11-27 | 2023-11-29 | 120,409 | $21.61 | $2.60M | 790,321 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other deriv | 2023-09-14 | 2023-09-15 | 1 | — | $0 | 490,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2023-09-14 | 2023-09-15 | 579,000 | $3.39 | $1.96M | 16,835,154 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2023-09-14 | 2023-09-15 | 579,000 | $3.39 | $1.96M | 16,256,154 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2023-08-15 | 2023-08-17 | 13,431,616 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2023-08-15 | 2023-08-17 | 2,924,761 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2023-08-15 | 2023-08-17 | 13,431,616 | $1.70 | $22.83M | 16,835,154 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2023-08-15 | 2023-08-17 | 2,924,761 | $2.10 | $6.14M | 3,403,538 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | J Other | 2023-07-03 | 2023-07-03 | 670,466 | — | $0 | 7,797,454 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | J Other | 2023-06-29 | 2023-07-03 | 108,879 | — | $0 | 8,467,920 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2023-06-19 | 2023-06-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2023-05-31 | 2023-06-02 | 36,353 | — | $0 | 36,353 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2023-05-31 | 2023-06-02 | 18,176 | — | $0 | 18,176 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-09-06 | 2022-09-07 | 250,000 | $5.62 | $1.41M | 10,643,627 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-08-04 | 2022-08-05 | 255,173 | $1.75 | $446.6K | 11,444,836 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-08-03 | 2022-08-05 | 46,009 | $1.74 | $80.1K | 11,189,663 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-08-02 | 2022-08-02 | 272,618 | $1.64 | $447.1K | 11,143,654 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-08-01 | 2022-08-02 | 210,200 | $1.48 | $311.1K | 10,871,036 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-07-29 | 2022-08-02 | 137,648 | $1.42 | $195.5K | 10,660,836 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-06-13 | 2022-06-15 | 100,000 | $1.70 | $170.0K | 10,523,188 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-06-03 | 2022-06-06 | 250,000 | $1.98 | $495.0K | 10,423,188 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-06-02 | 2022-06-06 | 200,000 | $1.92 | $384.0K | 10,173,188 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-05-25 | 2022-05-26 | 79,400 | $3.40 | $270.0K | 10,393,627 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-05-19 | 2022-05-19 | 85,000 | $5.81 | $493.8K | 10,314,227 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-05-18 | 2022-05-19 | 76,404 | $5.89 | $450.0K | 10,229,227 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-05-17 | 2022-05-19 | 59,700 | $5.99 | $357.6K | 10,152,823 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-05-10 | 2022-05-10 | 25,000 | $2.52 | $63.0K | 9,973,188 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-05-06 | 2022-05-10 | 463,350 | $2.90 | $1.34M | 9,948,188 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-05-02 | 2022-05-02 | 125,000 | $2.81 | $351.3K | 9,484,838 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-04-29 | 2022-05-02 | 247,400 | $2.66 | $658.1K | 9,359,838 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-04-28 | 2022-05-02 | 27,600 | $2.40 | $66.2K | 9,112,438 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-04-18 | 2022-04-18 | 1,764,705 | $5.10 | $9.00M | 10,093,123 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-04-12 | 2022-04-13 | 50,000 | $3.60 | $180.0K | 9,084,838 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-04-11 | 2022-04-13 | 145,000 | $3.87 | $561.1K | 9,034,838 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-04-08 | 2022-04-08 | 200,000 | $3.76 | $752.0K | 8,889,838 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-04-07 | 2022-04-08 | 200,000 | $3.88 | $776.0K | 8,689,838 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | P Buy | 2022-04-06 | 2022-04-08 | 109,573 | $3.60 | $394.5K | 8,489,838 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2021-08-20 | 2021-09-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2021-04-13 | 2021-04-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2021-04-13 | 2021-04-15 | 16,132 | — | $0 | 16,132 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer deriv | 2020-11-16 | 2020-11-17 | 9,452 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer deriv | 2020-11-16 | 2020-11-17 | 21,289 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer deriv | 2020-11-16 | 2020-11-17 | 6,000 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer | 2020-11-16 | 2020-11-17 | 14,676 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer | 2020-11-16 | 2020-11-17 | 3,499,428 | — | $0 | 0 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award deriv | 2020-06-02 | 2020-06-04 | 21,289 | — | $0 | 21,289 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award | 2020-06-02 | 2020-06-04 | 10,269 | — | $0 | 14,676 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award deriv | 2019-10-08 | 2019-10-10 | 9,452 | — | $0 | 9,452 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award deriv | 2019-10-08 | 2019-10-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award | 2019-10-08 | 2019-10-10 | 4,407 | — | $0 | 4,407 | SEC↗ |